CoapTech Raises New Funding Round Led by Good Growth Capital
The “Built in Baltimore” medical device company is delivering transformative solutions for minimally-invasive surgery
Baltimore, Md. (May 28, 2025) – CoapTech Inc., a Baltimore-based medical device company, announced today the initial close of a Series B funding round, which was led by Good Growth Capital, an early-stage venture capital firm that invests in transformative science and technology, with participation from the University System of Maryland (USM) Momentum Fund (Momentum Fund) and the University of Maryland, Baltimore (UMB), a previous investor. Additional funds joining the round included NuFund, TEDCO, The Abell Foundation, and Ecphora Capital.
The round will support commercial expansion of CoapTech’s PUMA System™, which enables novel minimally-invasive surgical procedures in hollow organs using point-of-care ultrasound. Previously, it was unsafe or impossible to use ultrasound in air-filled parts of the body. The FDA-cleared PUMA-G SystemTM, which is the first and only device enabling bedside ultrasound-based placement of gastrostomy feeding tubes, has been proven to significantly reduce per-patient hospital cost and ICU length of stay.
